Literature DB >> 12938516

Association between HPV 16/18 infection and expression of P53 protein in laryngeal papillomas.

H Chu1, E Reyt.   

Abstract

To understand the relationship between expression of P53 protein and HPV16/18 infection in laryngeal papillomas, PCR and immunohistochemical techniques were used to examine the paraffin-embedded tissue samples of laryngeal papillomas from 35 subjects. HPV 16/18-DNA was found in 24 cases of laryngeal papillomas (68.8%). Overexpression of P53 protein was detected in 19 cases (54.3%). Both HPV16/18-DNA and overexpression of P53 protein were demonstrated in 12 cases of laryngeal papillomas (34.3%). Our results suggest that HPV16/18 infection and P53 gene mutation are associated with pathogenesis of laryngeal papillomas. The relation between HPV infection and P53 mutation in tissues of laryngeal papillomas remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 12938516     DOI: 10.1007/bf02886961

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  4 in total

1.  Human papillomavirus infection and expression of p53 and c-erbB-2 protein in laryngeal papillomas.

Authors:  B Luzar; N Gale; V Kambic; M Poljak; N Zidar; A Vodovnik
Journal:  Acta Otolaryngol Suppl       Date:  1997

2.  Coinfection of HPV-11 and HPV-16 in a case of laryngeal squamous papillomas with severe dysplasia.

Authors:  K Y Lin; W H Westra; H K Kashima; P Mounts; T C Wu
Journal:  Laryngoscope       Date:  1997-07       Impact factor: 3.325

3.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.

Authors:  M Scheffner; B A Werness; J M Huibregtse; A J Levine; P M Howley
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

4.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.

Authors:  N Dyson; P M Howley; K Münger; E Harlow
Journal:  Science       Date:  1989-02-17       Impact factor: 47.728

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.